Asia Genomics
Latest round
- Series B
Last raised
- Dec 2019
Total raised
- $8.4M
Investors
- 4
About Asia Genomics
Based in Singapore, and founded in 2014 by its CEO Mun-Yew Wong, Asia Genomics Pte. Ltd. operates as a molecular diagnostics company specializing in clinical genomics and genetic testing. The company focuses on implementing genomic technologies with diagnostic laboratories to connect healthcare professionals with genetic tests, enabling clients to integrate scientific approaches with medical and technology partners. Asia Genomics arranges for all aspects of testing including swabbing, collection/courier, lab analysis, onsite pre-event antigen rapid test (ART) swabbing, polymerase chain reaction (PCR) testing, routine employee COVID-19 testing, pre-departure COVID-19 testing, clinical diagnostics, clinical screening, sequencing, genomics, cancer genetic tests, somatic cancer, hereditary cancer, liquid biopsy, NIPT, non-invasive prenatal test, genetic test, and solid biopsy.
Who invested in Asia Genomics
4 investors across 2 rounds
See all investors in Asia Genomics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Asia Genomics
Who invested in Asia Genomics?
Asia Genomics has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Asia Genomics raised?
Asia Genomics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Asia Genomics last raise money?
Asia Genomics's most recent round on record is a Series B, in Dec 2019.
What does Asia Genomics do?
Based in Singapore, and founded in 2014 by its CEO Mun-Yew Wong, Asia Genomics Pte.
Where is Asia Genomics headquartered?
Asia Genomics is headquartered in Singapore.
Which VCs invest in companies like Asia Genomics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Asia Genomics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Asia Genomics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.